Literature DB >> 28220586

Prevalence of anxiety and depressive symptoms and their association with pelvic floor dysfunctions-A cross sectional cohort study at a Pelvic Care Centre.

Desiree Vrijens1,2, Bary Berghmans1, Fred Nieman3, Jim van Os4,5,6, Gommert van Koeveringe1,2,6, Carsten Leue1,4,6.   

Abstract

AIMS: Pelvic floor dysfunctions (PFDs), like voiding complaints, urinary and fecal incontinence, and prolapse, are prevalent and associated with decrease in quality of life. PFDs are often complex and multifactorial in origin showing interrelationships between different PFD and with affective conditions. The primary aim of this study is to describe the prevalence of affective complaints in a cohort of Pelvic Care Centre (PCC) patients. The secondary aim is to describe associations between PFDs and depression or anxiety.
METHODS: A cross sectional cohort study at an University Hospital's PCC. First contact patients were included in a triage system and filled out questionnaires regarding pelvic floor complaints and Hospital Anxiety and Depression Scale (HADS) scores. Linear (dummy-) regression analysis of HADS scales was performed to test the effects of relevant clinical predictors related, and not directly related, to pelvic floor problems, and demographic characteristics of the patients.
RESULTS: From 1862 eligible first-contact PCC patients, 1510 (mean age 57.1) had completed the questionnaire (352 missing, 18.9%). The prevalence of anxiety and depression complaints was 30.9% and 20.3%, respectively. The variance explained for depression score by PFDs was 0.12 and 0.074 for anxiety.
CONCLUSIONS: Anxiety and depression are prevalent (30.9% and 20.3%, respectively) in a cohort of PFDs. PFDs can explain variance within anxiety and depression complaints. Corrected for other contributing variables, 12% of depression and 7.4% of anxiety was directly related to PFDs. We advocate a multidisciplinary approach, containing psychometric assessment for PFDs in order to obtain better diagnostic results and personalized treatment options.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety; depression; fecal incontinence; pelvic floor dysfunction; pelvic organ prolapse; urinary incontinence

Mesh:

Year:  2017        PMID: 28220586     DOI: 10.1002/nau.23186

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

1.  Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary Incontinence.

Authors:  Nazema Y Siddiqui; Jonathan B Wiseman; David Cella; Catherine S Bradley; H Henry Lai; Margaret E Helmuth; Abigail R Smith; James W Griffith; Cindy L Amundsen; Kimberly S Kenton; J Quentin Clemens; Karl J Kreder; Robert M Merion; Ziya Kirkali; John W Kusek; Anne P Cameron
Journal:  J Urol       Date:  2018-05-03       Impact factor: 7.450

2.  Postpartum depression screening and pelvic floor symptoms among women referred to a specialty postpartum perineal clinic.

Authors:  Carolyn W Swenson; Julia A DePorre; Jessica K Haefner; Mitchell B Berger; Dee E Fenner
Journal:  Am J Obstet Gynecol       Date:  2017-12-08       Impact factor: 8.661

3.  Effect of generalized anxiety disorders on the success of pessary treatment for pelvic organ prolapse.

Authors:  Fang-Fang Ai; Meng Mao; Ye Zhang; Jia Kang; Lan Zhu
Journal:  Int Urogynecol J       Date:  2018-02-24       Impact factor: 2.894

4.  Women's experiences of managing digitation: do we ask enough in primary care?

Authors:  Sharon Eustice; Ruth Endacott; Jenny Morris; Rohit Shankar; Bridie Kent
Journal:  JRSM Open       Date:  2018-08-06

5.  Patient and economic benefits of psychological support for noncompliant patients.

Authors:  Phil Reed; Lisa A Osborne; C Mair Whittall; Simon Emery; Roberto Truzoli
Journal:  Front Psychol       Date:  2022-09-15

6.  Conceptualization and Inventory of the Sexual and Psychological Burden of Women With Pelvic Floor Complaints; A Mixed-Method Study.

Authors:  Alma M Brand; Scott Rosas; Wim Waterink; Slavi Stoyanov; Jacques J D M van Lankveld
Journal:  Sex Med       Date:  2022-03-23       Impact factor: 2.523

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.